Literature DB >> 11095798

Prosthetic Joint Infection.

.   

Abstract

Total joint replacement has been one of the most remarkable successes of modern medical technology. Once John Charnley had solved the problems of implant design, choice of materials, implant fixation, and infection (initial rates of infection were approximately 10%), the way was clear for the widespread use of this valuable treatment, which is highly effective at removing pain and restoring function. Unfortunately, infection still remains an important, though less common, problem. It is associated with serious morbidity (pain, loss of function, wound breakdown, wound discharge, implant failure) and sometimes mortality. It may be impossible to eradicate or suppress infection in the long term without removal of the prosthesis, and most clinicians would consider it unwise to re-implant a new prosthesis in the presence of infection. Hence, patients with infected prosthetic joints generally require multiple additional operations and prolonged periods of antibiotic therapy. Even radical attempts at cure may fail (in 10% to 15% of cases in most series), requiring further cycles of treatment with progressively deteriorating function. Thus, the treatment of prosthetic joint infection is arduous for the patient and the health care team, with no guarantee of success.

Entities:  

Year:  1999        PMID: 11095798     DOI: 10.1007/s11908-999-0029-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  28 in total

1.  Improved detection of infection in hip replacements. A currently underestimated problem.

Authors:  M M Tunney; S Patrick; S P Gorman; J R Nixon; N Anderson; R I Davis; D Hanna; G Ramage
Journal:  J Bone Joint Surg Br       Date:  1998-07

2.  Vancomycin-resistant Staphylococcus aureus: infection control considerations.

Authors:  R P Wenzel; M B Edmond
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

3.  One stage revision arthroplasty of the hip for deep gram negative infection.

Authors:  V V Raut; M S Orth; M C Orth; P D Siney; B M Wroblewski
Journal:  Int Orthop       Date:  1996       Impact factor: 3.075

4.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.

Authors:  C M Brandt; W W Sistrunk; M C Duffy; A D Hanssen; J M Steckelberg; D M Ilstrup; D R Osmon
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

5.  Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

Authors:  A F Widmer; R Frei; Z Rajacic; W Zimmerli
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

6.  Risk factors for prosthetic joint infection: case-control study.

Authors:  E F Berbari; A D Hanssen; M C Duffy; J M Steckelberg; D M Ilstrup; W S Harmsen; D R Osmon
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

7.  Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology.

Authors:  S Meghji; S J Crean; P A Hill; M Sheikh; S P Nair; K Heron; B Henderson; E B Mawer; M Harris
Journal:  Br J Rheumatol       Date:  1998-10

8.  Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.

Authors:  S N Coulter; W R Schwan; E Y Ng; M H Langhorne; H D Ritchie; S Westbrock-Wadman; W O Hufnagle; K R Folger; A S Bayer; C K Stover
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

9.  Gentamicin release from old cement during revision hip arthroplasty.

Authors:  J W Powles; R F Spencer; A M Lovering
Journal:  J Bone Joint Surg Br       Date:  1998-07

10.  Management of deep infection of total hip replacement.

Authors:  H W Buchholz; R A Elson; E Engelbrecht; H Lodenkämper; J Röttger; A Siegel
Journal:  J Bone Joint Surg Br       Date:  1981
View more
  2 in total

1.  [Knee joint infections].

Authors:  S Oestern; D Varoga; R Trompetter; S Lippross; T Klüter; M Weuster; O Schröder; A Seekamp
Journal:  Unfallchirurg       Date:  2013-03       Impact factor: 1.000

2.  A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin.

Authors:  Elizabeth D Hermsen; Luke Mendez-Vigo; Elie F Berbari; Thomas Chung; Minjung Yoon; Kenneth C Lamp
Journal:  BMC Infect Dis       Date:  2016-06-24       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.